Detection of elafin as a candidate biomarker for ulcerative colitis by whole-genome microarray screening

Inflammatory Bowel Diseases

Volumn 12, Issue 9, 2006, Pages 837-842

  Flach, Carl Fredrik ^a   Eriksson, Anders ^b   Jennische, Eva ^a   Lange, Stefan ^a   Gunnerek, Charina ^c   Lönnroth, Ivar ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Kärnsjukhuset ^*  (Sweden)

Author keywords

Aldolase B; Elafin; Microarray; SLC6A14; Ulcerative colitis

Indexed keywords

ALDOLASE B; AMINO ACID TRANSPORTER; BIOLOGICAL MARKER; ELAFIN; FRUCTOSE BISPHOSPHATE ALDOLASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PROTEIN SLC6A14; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; GENE; GENETIC CODE; GOBLET CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; INTESTINE CELL; LOC 405753 GENE; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM BIOPSY; RECTUM MUCOSA; RNA TRANSCRIPTION; ULCERATIVE COLITIS; UPREGULATION;

ADULT; BIOLOGICAL MARKERS; BIOPSY; COLITIS, ULCERATIVE; ELAFIN; FEMALE; FRUCTOSE-BISPHOSPHATE ALDOLASE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECTUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33748468190     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.mib.0000232469.23574.11     Document Type: Article

References (19)

1. Ekbom A, Helmick C, Zack M, et al. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology. 1991;100:350-358.
2. Moum B, Vatn MH, Ekbom A, et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol. 1996;31:362-366.
3. Ekbom A. The epidemiology of IBD: a lot of data but little knowledge. How shall we proceed? Inflamm Bowel Dis. 2004;10(Suppl 1):S32-S34.
4. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182-205.
5. Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science. 2005;307:1920-1925.
6. Mah N, Thelin A, Lu T, et al. A comparison of oligonucleotide and cDNA-based microarray systems. Physiol Genomics. 2004;16:361-370.
7. Tan PK, Downey TJ, Spitznagel EL Jr, et al. Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res. 2003;31:5676-5684.
8. Dieckgraefe BK, Stenson WF, Korzenik JR, et al. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics. 2000;4:1-11.
9. Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet. 2001;10:445-456.
10. Masuda H, Takahashi Y, Asai S, et al. Distinct gene expression of osteopontin in patients with ulcerative colitis. J Surg Res. 2003;111:85-90.
11. Langmann T, Moehle C, Mauerer R, et al. Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology. 2004;127:26-40.
12. Flach CF, Lange S, Jennische E, et al. Cholera toxin induces expression of ion channels and carriers in rat small intestinal mucosa. FEBS Lett. 2004;561:122-126.
13. Simpson AJ, Maxwell AI, Govan JR, et al. Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens. FEBS Lett. 1999;452:309-313.
14. Mager S, Sloan J. Possible role of amino acids, peptides, and sugar transporter in protein removal and innate lung defense. Eur J Pharmacol. 2003;479:263-267.
15. Sallenave JM. Antimicrobial activity of antiproteinases. Biochem Soc Trans. 2002;30:111-115.
16. Bohe M. Pancreatic and granulocytic endoproteases in faecal extracts from patients with active ulcerative colitis. Scand J Gastroenterol. 1987;22:59-64.
17. Tjabringa GS, Vos JB, Olthuis D, et al. Host defense effector molecules in mucosal secretions. FEMS Immunol Med Microbiol. 2005;45:151-158.
18. Wachsmuth ED. Differentiation of epithelial cells in human jejunum: localization and quantification of aminopeptidase, alkaline phosphatase and aldolase isozymes in tissue sections. Histochemistry. 1976;48:101-109.
19. Sloan JL, Mager S. Cloning and functional expression of a human Na(+) and Cl(-)-dependent neutral and cationic amino acid transporter B(0+). J Biol Chem. 1999;274:23740-23745.